Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

TD Cowen Maintains Buy on Guardant Health, Raises Price Target to $72

Author: Benzinga Newsdesk | September 25, 2025 01:52pm
TD Cowen analyst Dan Brennan maintains Guardant Health (NASDAQ: GH) with a Buy and raises the price target from $63 to $72.

Posted In: GH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist